Entry to the list of donations to the Foundation transparent account

Insulin

Lantus (Insulin Glargine)
0

Lantus (Insulin Glargine)

November 20th, 2015 | by Great Britain Association
Insulin glargine is a long acting analogue insulin Lantus is an analogue insulin produced by Sanofi-Aventis with the medical name insulin glargine. Lantus has been available for pharmaceutical use since the year 2000. Lantus hit
Tresiba (Insulin Degludec)
0

Tresiba (Insulin Degludec)

November 20th, 2015 | by Great Britain Association
Insulin degludec is an ultra long acting basal insulin Insulin degludec, which is supplied under trade name Tresiba, is an ultra long acting basal insulin which can be used by people with type 1 or type 2 diabetes. Tresiba last
New perspectives on insulin resistance
0

New perspectives on insulin resistance

October 1st, 2015 | by American Association
Muscle Whole-body insulin resistance is the earliest predictor of type 2 diabetes onset, and this mainly reflects muscle insulin resistance. However, careful separation of the contributions of muscle and liver have shown that
Insulin Resistance
0

Insulin Resistance

July 14th, 2015 | by Great Britain Association
Insulin resistance occurs when insulin levels are sufficiently high over a prolonged period of time causing the body’s own sensitivity to the hormone to be reduced. Once the body starts to get resistant to insulin, it can be a